To explore the impact of EGCG treatment on the intestinal microenvironment in colitis, we performed a comprehensive analysis of various immune cells, including CD4+ T, CD8αβ+ T, CD79a+ B cells, and F4/80+ macrophages, using flow cytometry (Fig. S1B). The gene discussed is CD79A; the disease is colitis.